Starpharma Holdings Limited
SPHRY · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $36,131 | $36,801 | $128,906 | $279,943 |
| - Cash | $15,407 | $23,360 | $35,180 | $49,918 |
| + Debt | $2,402 | $3,528 | $8,272 | $8,189 |
| Enterprise Value | $23,126 | $16,969 | $101,998 | $238,214 |
| Revenue | $5,850 | $8,289 | $4,343 | $5,162 |
| % Growth | -29.4% | 90.9% | -15.9% | – |
| Gross Profit | -$3,729 | $7,657 | $1,223 | $1,906 |
| % Margin | -63.7% | 92.4% | 28.1% | 36.9% |
| EBITDA | -$9,723 | -$9,632 | -$17,042 | -$15,798 |
| % Margin | -166.2% | -116.2% | -392.4% | -306% |
| Net Income | -$9,990 | -$8,165 | -$15,638 | -$16,154 |
| % Margin | -170.8% | -98.5% | -360.1% | -312.9% |
| EPS Diluted | -0.24 | -0.2 | -0.38 | -0.4 |
| % Growth | -20% | 47.4% | 5% | – |
| Operating Cash Flow | -$6,759 | -$6,977 | -$13,533 | -$13,162 |
| Capital Expenditures | -$42 | -$89 | -$621 | -$837 |
| Free Cash Flow | -$6,801 | -$7,066 | -$14,154 | -$13,999 |